Legend Biotech Corp share price logo

Legend Biotech Corp Share Price

NASDAQ: LEGN

Large Cap

$35.74

+0.75

(+2.14%)

Live

as on

Legend Biotech Corp Stock Performance

as on September 6, 2025 at 12:37 am IST

  • Day's Low

    Day's High

    $35.43
    $36.48
    downward going graph

    0.87%

    Downside

    2.07%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $27.34
    $57.54
    downward going graph

    23.50%

    Downside

    61.00%

    Upside

    downward going graph

Legend Biotech Corp share price movements today

Previous Close
$34.99
Open
$35.70
Volume
1.2M
Day's Low - High
$35.43 - $36.48
52 Week Low - High
$27.34 - $57.54

Legend Biotech Corp Historical Returns

1 Month Return
-8.93 %
3 Month Return
+ 11.15 %
1 Year Return
-35.26 %
3 Year Return
-24.15 %
5 Year Return
+ 18.33 %

Legend Biotech Corp Stock Fundamentals & Key Indicators

Check Legend Biotech Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.5B

EPS (TTM)

-0.6774

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-209.0M

Revenue (TTM)

796.8M

Profit Margin

-40.83%

Return On Equity TTM

18161400.00%

Legend Biotech Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Legend Biotech Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$6.5B18.33%NA-40.83%
BUY$59.4B269.24%-505.15-12.96%
NA$39.4BNANA-3.89%
BUY$101.8B48.94%28.2531.86%
BUY$59.8B-2.26%14.2131.37%

Stock Returns calculator for Legend Biotech Corp Stock including INR - Dollar returns

The Legend Biotech Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Legend Biotech Corp investment value today

Current value as on today

₹71,178

Returns

₹28,822

(-28.82%)

Returns from Legend Biotech Corp Stock

₹33,876 (-33.88%)

Dollar Returns*

₹5,054 (+5.05%)

Analyst Recommendation on Legend Biotech Corp Stock

Based on 27 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 27 analysts, 88.89% of analysts recommend a 'BUY' rating for Legend Biotech Corp. Average target price of $77.27

Legend Biotech Corp Share Price Target

Get share price movements and forecasts by analysts on Legend Biotech Corp.

What analysts predicted

53.75%UPSIDE

Target Price

$77.27

Current Price

$35.74

Analyzed by

27 Analysts

Target

$77.27

Legend Biotech Corp target price $77.27, a slight upside of 53.75% compared to current price of $35.74. According to 27 analysts rating.

Legend Biotech Corp Stock's Interest Amongst Investors

Search interest for Legend Biotech Corp Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:11% versus previous 30 day period

Legend Biotech Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
36
73
96
79
93
186
160
186
195
255
Gross Profit
0
40
52
41
33
136
104
112
123
151
Operating Income
-106
-88
-66
-121
-117
-41
-70
-74
-50
-21
EBITDA
-106
-193
-51
-135
-48
-7
-109
52
-88
-114
Interest Expense
5
5
5
5
5
5
5
5
5
5
Depreciation
5
-
5
5
5
5
5
6
5
5
Income Before Tax
-111
-198
-62
-146
-59
-17
-120
40
-99
-125
Income Tax Expense
0
0
0
-1
0
0
4
14
1
0
Net Income
-112
-199
-62
-144
-59
-18
-125
26
-100
-125
Net Profit Margin
-308.51%
-271.55%
-64.79%
-182.24%
-63.62%
-9.76%
-78.23%
14.09%
-51.74%
-49.16%

Legend Biotech Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
23
49
57
75
89
117
285
627
Gross Profit
23
49
57
-156
-223
51
140
392
Operating Income
13
-1
-130
-313
-393
-455
-439
-303
EBITDA
14
0
-124
-294
-392
-416
-477
-113
Interest Expense
-
0
0
4
0
10
21
21
Depreciation
-
1
5
9
13
18
20
23
Income Before Tax
13
-1
-130
-307
-386
-445
-520
-158
Income Tax Expense
4
1
2
-4
0
0
-1
18
Net Income
9
-2
-132
-303
-386
-446
-518
-177
Net Profit Margin
39.69%
-5.67%
-232.21%
-401.02%
-430.12%
-381.48%
-181.75%
-28.22%

Legend Biotech Corp Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-198
-62
-144
-59
-18
-120
40
-99
-124
Operating Cash Flow
-95
-60
-93
16
-1
-75
-82
-103
-13
Investing Cash Flow
-123
-209
405
-396
-695
329
-87
256
-165
Financing Cash Flow
789
0
0
0
0
4
0
0
0
Change in Cash
573
-269
314
-380
-696
258
-172
154
-175

Legend Biotech Corp Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-1
-130
-307
-386
-445
-518
-158
Operating Cash Flow
307
-83
-223
-198
-200
-393
-144
Investing Cash Flow
-102
-58
-24
-194
-78
92
-850
Financing Cash Flow
2
14
618
626
377
791
5
Change in Cash
208
-126
372
233
97
491
-990

Global Institutional Holdings in Legend Biotech Corp

Funds
Holdings
FMR Inc
7.18%
Westfield Capital Management Company, L.P.
3.76%
T. Rowe Price Associates, Inc.
3.66%
Hillhouse Capital Advisors, Ltd.
3.25%
BlackRock Inc
2.46%

Insights on Legend Biotech Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 160.20M → 255.95M (in $), with an average increase of 14.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 80.4% return, outperforming this stock by 115.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 120.8% return, outperforming this stock by 145.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 26.28M → -125.82M (in $), with an average decrease of 254.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, LEGN stock has moved down by -9.1%

About Legend Biotech Corp

legend biotech corporation is an emerging company focusing on the development of the best-in-class immunotherapy technology for cancer cure. teamed up with outstanding immunologists and molecular biologists, legend has generated a strong pipeline of chimeric antigen receptor(car) product candidates to treat a wide variety of liquid and solid tumors. our ambition to succeed in the cars field has been substantially fulfilled by the latest clinical trial results that we have achieved a great clinical success in treating multiple myeloma, a previously incurable blood cancer. by applying one of our proprietary car-t technology, we have reached a promising result in the clinical research for the enrolled patient group bearing refractory and relapsed multiple myeloma. legend biotech corporation is founded on the vision that the previous incurable previousincurable cancer will be safely and effectively treated with fine-tuning products generated on our innovative technology platform. we take o
OrganisationLegend Biotech Corp
Headquarters2101 Cottontail Lane, Somerset, NJ, United States, 08873
IndustryCommercial Services
CEODr. Ying Huang Ph.D.
E-voting on sharesClick here to vote

Key Management of Legend Biotech Corp

Name

Title

Mr. Tim Roberts

Global Compliance Officer

Ms. Elaine Qian

VP & Global Head of Human Resources

Dr. Guowei Fang Ph.D.

President of Research & Development

Dr. Mythili Koneru M.D., Ph.D.

Chief Medical Officer

Dr. Ying Huang Ph.D.

CEO & Director

Mr. Carlos Santos

Chief Financial Officer

Ms. Jessie Yeung M.B.A.

Vice President of Finance, Investor & Public Relations

Mr. James Pepin J.D.

General Counsel

Mr. Birk Vanderweeen

Senior Vice President of Global Manufacturing & Supply

Mr. Alan S. Bash

President of CARVYKTI®

FAQs

What is Legend Biotech Corp share price today?

Legend Biotech Corp share price today is $35.74 as on . Legend Biotech Corp share today touched a day high of $36.48 and a low of $35.43.

What is the 52 week high and 52 week low for Legend Biotech Corp share?

Legend Biotech Corp share touched a 52 week high of $57.54 on and a 52 week low of $27.34 on . Legend Biotech Corp stock price today i.e. is trending at $35.74,which is 37.89% down from its 52 week high and 30.72% up from its 52 week low.

What is Legend Biotech Corp's market capitalisation today?

Legend Biotech Corp market capitalisation is $0.01T as on .

How to invest in Legend Biotech Corp Stock (LEGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Legend Biotech Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Legend Biotech Corp Shares that will get you 0.0420 shares as per Legend Biotech Corp share price of $35.74 per share as on September 6, 2025 at 12:37 am IST.

What is the minimum amount required to buy Legend Biotech Corp Stock (LEGN) from India?

Indian investors can start investing in Legend Biotech Corp (LEGN) shares with as little as ₹88.233 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.33 in Legend Biotech Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Legend Biotech Corp share’s latest price of $35.74 as on September 6, 2025 at 12:37 am IST, you will get 0.2798 shares of Legend Biotech Corp. Learn more about fractional shares .

What are the returns that Legend Biotech Corp has given to Indian investors in the last 5 years?

Legend Biotech Corp stock has given 18.33% share price returns and 19.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?